Shan Lu

1.7k total citations
35 papers, 1.3k citations indexed

About

Shan Lu is a scholar working on Molecular Biology, Pharmacology and Cell Biology. According to data from OpenAlex, Shan Lu has authored 35 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Molecular Biology, 6 papers in Pharmacology and 4 papers in Cell Biology. Recurrent topics in Shan Lu's work include Peroxisome Proliferator-Activated Receptors (5 papers), Inflammatory mediators and NSAID effects (4 papers) and Mitochondrial Function and Pathology (3 papers). Shan Lu is often cited by papers focused on Peroxisome Proliferator-Activated Receptors (5 papers), Inflammatory mediators and NSAID effects (4 papers) and Mitochondrial Function and Pathology (3 papers). Shan Lu collaborates with scholars based in China, United States and Japan. Shan Lu's co-authors include Wei Li, Dan Shen, Bing Zhou, Libo Sun, Chuanxiong Guo, Kun Tan, Haitao Wu, Faquan Liang, David G. Gardner and Meihua Piao and has published in prestigious journals such as Nucleic Acids Research, Neuron and SHILAP Revista de lepidopterología.

In The Last Decade

Shan Lu

34 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shan Lu China 16 626 182 171 166 158 35 1.3k
Ran Duan China 20 381 0.6× 102 0.6× 131 0.8× 39 0.2× 27 0.2× 67 1.2k
Feng Xiao China 25 1.3k 2.1× 135 0.7× 309 1.8× 53 0.3× 34 0.2× 103 2.0k
Masashi Maekawa Japan 17 863 1.4× 57 0.3× 88 0.5× 25 0.2× 37 0.2× 65 1.2k
Hongtao Ma China 15 591 0.9× 99 0.5× 82 0.5× 44 0.3× 31 0.2× 27 1.3k
Dan Du China 17 539 0.9× 28 0.2× 63 0.4× 72 0.4× 40 0.3× 57 1.0k
Lijun Wu China 21 623 1.0× 26 0.1× 165 1.0× 27 0.2× 54 0.3× 46 2.4k
Gang Feng China 20 1.3k 2.1× 111 0.6× 230 1.3× 11 0.1× 20 0.1× 45 2.0k
Haoyu Li China 16 279 0.4× 35 0.2× 56 0.3× 27 0.2× 24 0.2× 109 908
Jonathan B. Rosenberg United States 26 735 1.2× 43 0.2× 41 0.2× 32 0.2× 18 0.1× 68 1.7k

Countries citing papers authored by Shan Lu

Since Specialization
Citations

This map shows the geographic impact of Shan Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shan Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shan Lu more than expected).

Fields of papers citing papers by Shan Lu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shan Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shan Lu. The network helps show where Shan Lu may publish in the future.

Co-authorship network of co-authors of Shan Lu

This figure shows the co-authorship network connecting the top 25 collaborators of Shan Lu. A scholar is included among the top collaborators of Shan Lu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shan Lu. Shan Lu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tao, Xiaoyu, Shan Lu, Zhiqi Li, et al.. (2025). Co-administration of berberine and evodiamine: Mitigating evodiamine-induced hepatotoxicity and potentiating colitis treatment. Phytomedicine. 147. 157185–157185. 2 indexed citations
2.
Lu, Shan, et al.. (2025). From mechanism to targeted therapy: Advances in histone lactylation‑driven cancer progression (Review). Oncology Letters. 31(1). 1–17. 1 indexed citations
3.
Li, Chen, Zhao Zhang, Shan Lu, et al.. (2025). Targeting PPARα activation sensitizes glioblastoma cells to temozolomide and reverses acquired resistance by inhibiting H3K18 lactylation. Acta Pharmacologica Sinica. 46(11). 3071–3086. 3 indexed citations
4.
5.
Wang, Ruihan, Fangqian Wang, Shan Lu, et al.. (2023). Adipose-derived stem cell/FGF19-loaded microfluidic hydrogel microspheres for synergistic restoration of critical ischemic limb. Bioactive Materials. 27. 394–408. 21 indexed citations
6.
Lu, Shan, Jiaojiao Hu, Alexander Goginashvili, et al.. (2022). Heat-shock chaperone HSPB1 regulates cytoplasmic TDP-43 phase separation and liquid-to-gel transition. Nature Cell Biology. 24(9). 1378–1393. 80 indexed citations
7.
Lu, Shan, et al.. (2021). Scarless engineering of the Drosophila genome near any site-specific integration site. Genetics. 217(3). 5 indexed citations
8.
Lu, Shan, et al.. (2021). α-Tubulin Regulates the Fate of Germline Stem Cells in Drosophila Testis. Scientific Reports. 11(1). 10644–10644. 2 indexed citations
9.
Luo, Yun, Xi Dong, Shan Lu, et al.. (2021). Gypenoside XVII alleviates early diabetic retinopathy by regulating Müller cell apoptosis and autophagy in db/db mice. European Journal of Pharmacology. 895. 173893–173893. 37 indexed citations
10.
Hwang, Eun Jung, Shan Lu, Eric Hou-Jen Wang, et al.. (2019). Corticostriatal Flow of Action Selection Bias. Neuron. 104(6). 1126–1140.e6. 32 indexed citations
11.
Ding, Ye, Chuan He, Shan Lu, et al.. (2019). MLKL contributes to shikonin-induced glioma cell necroptosis via promotion of chromatinolysis. Cancer Letters. 467. 58–71. 50 indexed citations
12.
Xing, Xiaoyan, Yun Luo, Xuehong Deng, et al.. (2018). Notoginsenoside R1prevents H9c2 cardiomyocytes apoptosis against hypoxia/reoxygenationviathe ERs/PI3K/Akt pathway. RSC Advances. 8(25). 13871–13878. 6 indexed citations
13.
14.
Wang, Zongqi, Ye Ding, Xuanzhong Wang, et al.. (2018). Pseudolaric acid B triggers ferroptosis in glioma cells via activation of Nox4 and inhibition of xCT. Cancer Letters. 428. 21–33. 174 indexed citations
15.
O’Brien, Carol, Ajay Pandita, Jill M. Spoerke, et al.. (2013). Acquired PIK3CA amplification causes resistance to selective phosphoinositide 3-kinase inhibitors in breast cancer. Oncogenesis. 2(12). e83–e83. 66 indexed citations
16.
Lu, Shan, et al.. (2012). Persistent inflammation increases GABA-induced depolarization of rat cutaneous dorsal root ganglion neurons in vitro. Neuroscience. 220. 330–340. 31 indexed citations
17.
He, Wei, Xin Li, Jiajing Chen, et al.. (2010). Genetic linkage analyses andCx50mutation detection in a large multiplex Chinese family with hereditary nuclear cataract. Ophthalmic Genetics. 32(1). 48–53. 11 indexed citations
18.
Guo, Chuanxiong, et al.. (2009). FiConn: Using Backup Port for Server Interconnection in Data Centers. 2276–2285. 174 indexed citations
19.
Li, Wei, et al.. (2005). Yeast Model Uncovers Dual Roles of Mitochondria in the Action of Artemisinin. PLoS Genetics. 1(3). e36–e36. 238 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ran Duan Breakdown of academic impact, for papers by Feng Xiao Breakdown of academic impact, for papers by Masashi Maekawa Breakdown of academic impact, for papers by Hongtao Ma Breakdown of academic impact, for papers by Dan Du Breakdown of academic impact, for papers by Lijun Wu Breakdown of academic impact, for papers by Gang Feng Breakdown of academic impact, for papers by Haoyu Li Breakdown of academic impact, for papers by Jonathan B. Rosenberg
Rankless by CCL
2026